BioKier Overview

  • Founded
  • 2008
  • Status
  • Private
  • Employees
  • 3
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $3.73M
Latest Deal Amount
  • Investors
  • 4

BioKier General Information


Opertor of medical food and pharmaceutical company designed to offer treatment for diabetes and related disorders. The company's foods and drugs are developed to mimic the mechanism through which metabolic bypass surgery processes, enabling doctors to improve or resolve diabetes in the significant majority of patients that undergo the bypass surgery for obesity.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Other Industries
Drug Discovery
Primary Office
  • 105 Green Willow Court
  • Chapel Hill, NC 27514
  • United States
+1 (919) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

BioKier Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Grant 01-Jan-2019 $3.73M 00.000 Completed Generating Revenue
6. Later Stage VC 26-Sep-2014 00000 00.000 Completed Generating Revenue
5. Seed Round 24-Jul-2013 00.000 00.000 Completed Generating Revenue
4. Angel (individual) 04-Jun-2013 00000 00.000 Completed Generating Revenue
3. Debt - General 14-May-2013 00000 00000 Completed Generating Revenue
2. Debt - General 12-Oct-2010 $250K $500K Completed Generating Revenue
1. Angel (individual) 14-Oct-2009 $250K $250K Completed Generating Revenue
To view BioKier’s complete valuation and funding history, request access »

BioKier Executive Team (3)

Name Title Board Seat Contact Info
Jerzy Szewczyk Ph.D Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member
Roger Nolan Ph.D Chief Operating Officer, Board Member, President & Co-Founder
W. Bennett Love Chief Financial Officer (Part Time) & Vice President
To view BioKier’s complete executive team members history, request access »

BioKier Board Members (3)

Name Representing Role Since
James Farrelly Self Board Member 000 0000
Jerzy Szewczyk Ph.D BioKier Co-Founder, Chief Executive Officer, Chief Scientific Officer & Board Member 000 0000
Maria Berkman MD Broadview Ventures Board Observer 000 0000
To view BioKier’s complete board members history, request access »

BioKier Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

BioKier Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
National Institutes of Health Government 000 0000 000000 0
U.S. Department of Health and Human Services Government 000 0000 000000 0
Broadview Ventures Venture Capital Minority 000 0000 000000 0
Science & Technology Accelerator Program Accelerator/Incubator Minority 000 0000 000000 0
To view BioKier’s complete investors history, request access »